Significant Role of CPhI China 2018 to the Chinese Pharmaceutical Industry

For any industry, the regular holding of industry exhibitions every year will not only promote trade and increase sales volume, but also offer discussion and analysis of some issues of the industry, to promote the sound development of the industry. In particular, the industry exhibitions have become more frequent with increasingly large scales in recent years, which shall be paid more attention to.

The two well-known pharmaceutical exhibitions CPhI China 2018 and API China 2018 gather in Shanghai in 2018, which will attract many famous Chinese and overseas pharmaceutical enterprises to participate. This is an exciting message to all Chinese pharmaceutical manufacturers, as what they can get from the participation in CPhI China 2018 and API China 2018 is more than wealth.

Since 2000, the successful holding of the first CPhI China gave insight that the exhibition is not only a promotion campaign to exhibit merchants’ products and technologies, develop channels, promote sales, and spread brands, but also a concrete embodiment of the overall national strength of a country. Chinese enterprises need to question how to catch up with the pharmaceutical levels of developed countries under the circumstance of such a late start, reduce costs of import and patent purchase, and conduct independent R&D and production, and then seek solutions therefor.

Over all those years when CPhI China 2018 and API China 2018 took root in the medical world of China, CPhI China 2018 and API China 2018 have constantly extended upstream and downstream the industry chain; they have built an authoritative platform in the API industry, led a batch of API enterprises towards the world, and also looked through the industry development, constantly sought for changes, subdivided the industry plates, and extended upstream and downstream the industry chain.

In 2017, the CPhI China 2017 exhibition hosted by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products reached an exhibition scale of 160,000m², and attracted over 2,800 Chinese and overseas enterprises to exhibit, and 65,000-person-time visitors.

The cultivation of the two pharmaceutical exhibitions CPhI China 2018 and API China 2018 in Shanghai has played a role that cannot be ignored to the Chinese pharmaceutical industry, especially after China joined WTO and held Olympics and World Expo, which let more people know China and be willing to come to China. CPhI China 2018 and API China 2018 will create a good atmosphere for Chinese pharmaceutical enterprises to go abroad.

Register as Visitor to CPhI China 2018!